Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-21 to 2025-06-12
Current total value of award: $7441.92
Description: 4568382993!XOLAIR 300 MG/2 ML SYRINGE 2ML